Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 40 are a BUY (75.47%), 11 are a HOLD (20.75%), 2 are a SELL (3.77%).
Analyst Whitney Ijem works at CANACCORD with a stock forecast success ratio of 30.74% fulfilled within 205.22 days on average.
Whitney Ijem’s has documented 105 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 12-Apr-2024.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
167
$42.75 (34.41%)
174
1 months 24 days ago
1/6 (16.67%)
$38.33 (29.79%)
39
Buy
172
$47.75 (38.43%)
113
1 months 27 days ago
1/3 (33.33%)
$44.1 (34.48%)
27
Buy
157
$32.75 (26.36%)
151
1 months 27 days ago
10/39 (25.64%)
$29.1 (22.75%)
397
Hold
128
$3.75 (3.02%)
128
1 months 27 days ago
3/8 (37.5%)
$0.1 (0.08%)
61
Buy
166
$41.75 (33.60%)
169
1 months 27 days ago
8/19 (42.11%)
$38.1 (29.79%)
248
Which stock is Whitney Ijem is most bullish on?
Which stock is Whitney Ijem is most reserved on?
What Year was the first public recommendation made by Whitney Ijem?